Enema versus high doses of PEG 3350 in the treatment of rectal fecal impaction.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON23431

Enrollment

Registered

2006-02-07

Start date

2006-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood constipion

Interventions

At intake a standardized questionnaire is obtained by a physician to the parents and patient. Physical examination, including abdominal and rectal examination is acquired by the physician to define th

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 4-18 years; 2. Fecal impaction upon rectal exam.

Exclusion criteria

Exclusion criteria: 1. Previous colonic surgery; 2. Organic cause of constipation; 3. Allergy/sensitivity to PEG solutions or phosphates; 4. Allergy/sensitivity to sodium ducosate or sorbitol (“Klyx” enema).

Design outcomes

Primary

Measure	Time frame
Rectal fecal impaction evaluated by rectal examination/abdominal x-ray.	—

Secondary

Measure	Time frame
1. Defecation frequency/week; 2. Fecal incontinence frequency/week; 3. The number of side effects, such as abdominal pain, bloating, flatulence, nausea, bad taste; 4. Total and segmental colonic transit time.	—

Contacts

Public ContactMarc A. Benninga

Kinderarts MDL, AMC, H7-248 P.O. Box 22660

m.a.benninga@amc.nl+31 (0)20 5663053 / +31 (0)20 5666297

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)